Deep Analysis Earnings Calendar About

Home
/BKHA Black Hawk Acquisition Corp
/Deep Analysis

Black Hawk Acquisition CorpBKHAEarnings & Financial Report

Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)

Financial
Deep Analysis
Ownership
Annual Changes

PROK

PROKIDNEY CORP.

Revenue

$225.0K

Net Profit

N/A

VIR

Vir Biotechnology, Inc.

Revenue

$240.0K

Net Profit

$-163.1M

CRDF

Cardiff Oncology, Inc.

Revenue

$243.0K

Net Profit

$-7.2M

CKX

CKX LANDS, INC.

Revenue

$232.6K

Net Profit

$166.3K

ALGS

Aligos Therapeutics, Inc.

Revenue

$169.0K

Net Profit

N/A

PTHS

Pelthos Therapeutics Inc.

Revenue

$294.0K

Net Profit

$-16.2M

NOMA

Nomadar Corp.

Revenue

$378.1K

Net Profit

$-496.2K

INKT

MiNK Therapeutics, Inc.

Revenue

$111.2K

Net Profit

$-2.6M

PROK

PROKIDNEY CORP.

Revenue

$225.0K

Net Profit

N/A

VIR

Vir Biotechnology, Inc.

Revenue

$240.0K

Net Profit

$-163.1M

CRDF

Cardiff Oncology, Inc.

Revenue

$243.0K

Net Profit

$-7.2M

CKX

CKX LANDS, INC.

Revenue

$232.6K

Net Profit

$166.3K

ALGS

Aligos Therapeutics, Inc.

Revenue

$169.0K

Net Profit

N/A

PTHS

Pelthos Therapeutics Inc.

Revenue

$294.0K

Net Profit

$-16.2M

NOMA

Nomadar Corp.

Revenue

$378.1K

Net Profit

$-496.2K

INKT

MiNK Therapeutics, Inc.

Revenue

$111.2K

Net Profit

$-2.6M

The financial landscape of a US public company. Updated every quarter.

Explore

Home
Deep Analysis
Earnings Calendar

About

About
Terms
Contact Us

For informational purposes only. Not financial advice.

© 2026 10q10k.net · All rights reserved.